Alnylam and others have been pursuing ways to bring RNAi to the CNS. Atalanta, named for the mythical Greek huntress, makes its therapies with oligonucleotides, short pieces of synthetic RNA.

May 31 (Reuters) - Manager Gian Piero Gasperini confirmed his departure from Serie A side Atalanta with an emotional message to supporters on Saturday. Gasperini's exit did not come as a surprise ...

Big Pharma-backed Atalanta Therapeutics is ramping up for the clinical debut of the company’s lead epilepsy asset in the wake of new data showing the RNA therapy suppressed seizures in mice.